Epacadostat |
INCB-024360; 71596A9R13 (UNII code); INCB-24360 |
Phase 3 Clinical |
Incyte Corp |
Carcinoma, Squamous Cell; Sarcoma; Peritoneal Neoplasms; Thymus Neoplasms; Colorectal Neoplasms; Leukemia, B-Cell; Lymphoma; Esophageal Squamous Cell Carcinoma; Endometrial Neoplasms; Urogenital Neoplasms; Glioma; Urethral Neoplasms; Fallopian Tube Neoplasms; Lung Neoplasms; Carcinoma, Pancreatic Ductal; Thymoma; Esophageal adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma; Carcinoma, Hepatocellular; Adenocarcinoma; Carcinoma, Transitional Cell; Head and Neck Neoplasms; Ovarian Neoplasms; Lymphoma, B-Cell; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Rectal Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Abdominal Neoplasms; Small Cell Lung Carcinoma; Solid tumours; Neoplasms; Nasopharyngeal Neoplasms; Myelodysplastic Syndromes; Glioblastoma; Carcinoma, Ovarian Epithelial; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Nasopharyngeal Carcinoma; Prostatic Neoplasms |
Details
|
Puliginurad |
YL-90148 |
Phase 3 Clinical |
YL-Pharma |
Hyperuricemia; Gout |
Details
|
Linrodostat |
ONO-7701; BMS-986205 |
Phase 3 Clinical |
Bristol-Myers Squibb Company |
Solid tumours; Head and Neck Neoplasms; Stomach Neoplasms; Small Cell Lung Carcinoma; Neoplasms; Glioblastoma; Skin Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Squamous Cell; Mouth Neoplasms; Endometrial Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular; Laryngeal Diseases |
Details
|
IO-102 |
IO-102 |
Phase 2 Clinical |
Herlev Hospital, Merck Sharp & Dohme Corp, Io Biotech Aps |
Carcinoma, Squamous Cell; Mouth Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Indoximod |
1-MT; D-1MT; NLG-001; NLG-8189; NSC-721782 |
Phase 2 Clinical |
Newlink Genetics Co |
Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma; Leukemia, Myeloid, Acute; Lung Neoplasms; Glioma; Diffuse Intrinsic Pontine Glioma; Gliosarcoma; Prostatic Neoplasms; Solid tumours; Breast Neoplasms; Central Nervous System Neoplasms; Glioblastoma; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Medulloblastoma; Ependymoma |
Details
|
RiMO-301 |
RiMO-301 |
Phase 2 Clinical |
The University Of Chicago |
Head and Neck Neoplasms; Neoplasms |
Details
|
SHR-9146 |
HTI-1090; SHR-9146 |
Phase 1 Clinical |
Jiangsu Hengrui Medicine Co Ltd |
Solid tumours; Neoplasms |
Details
|
KHK-2455 |
KHK-2455 |
Phase 1 Clinical |
Kyowa Hakko Kirin Co Ltd |
Solid tumours; Carcinoma; Neoplasms; Carcinoma, Transitional Cell |
Details
|
LPM-3480226 |
LY-01013; LPM-3480226 |
Phase 1 Clinical |
Luye Pharma Group Ltd |
Solid tumours |
Details
|
DN-1406131 |
DN-131; DN-1406131 |
Phase 1 Clinical |
Jiangxi Qingfeng Pharmaceutical Industry Co Ltd, Shanghai De Novo Pharmatech Co Ltd |
Solid tumours; Melanoma; Carcinoma, Non-Small-Cell Lung |
Details
|
NLG802 |
NLG-802 |
Phase 1 Clinical |
Lankenau Institute For Medical Research |
Solid tumours |
Details
|
MK-7162 |
MK-7162 |
Phase 1 Clinical |
Merck Sharp & Dohme Corp |
Solid tumours |
Details
|
Navoximod |
NLG-919; RG-6078; GDC-0919 |
Phase 1 Clinical |
Lankenau Institute For Medical Research, Lumos Pharma Inc |
Solid tumours |
Details
|